Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy R Duvall

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Nature Chemical Biology|October 25, 2016
Structural and conformational determinants of macrocycle cell permeabilityBjörn Over, Pär Matsson, Christian Tyrchan, et al.
The Journal of Organic Chemistry|May 23, 2013
Synthesis of stereochemically and skeletally diverse fused ring systems from functionalized C-glycosidesBaudouin Gerard, Maurice D Lee, Sivaraman Dandapani, et al.
Journal of Computer-Aided Molecular Design|April 16, 2013
An informatic pipeline for managing high-throughput screening experiments and analyzing data from stereochemically diverse librariesCarol A Mulrooney, David L Lahr, Michael J Quintin, et al.
Chemistry & Biology|May 28, 2013
Selective HDAC1/HDAC2 inhibitors induce neuroblastoma differentiationStacey M Frumm, Zi Peng Fan, Kenneth N Ross, et al.
Journal of Medicinal Chemistry|July 24, 2023
Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug ConjugatesJeremy R Duvall, Joshua D Thomas, Raghida A Bukhalid, et al.
ACS Infectious Diseases|February 21, 2017
Identification of Highly Specific Diversity-Oriented Synthesis-Derived Inhibitors of Clostridium difficileJeremy R Duvall, Leanne Bedard, Adel M Naylor-Olsen, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Diversity-oriented synthesis yields a new drug lead for treatment of chagas diseaseSivaraman Dandapani, Andrew R Germain, Ivan Jewett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2025
XMT-2056, a HER2-Directed STING Agonist Antibody-Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune CellsRaghida A Bukhalid, Jeremy R Duvall, Kelly Lancaster, et al.
Journal of Medicinal Chemistry|September 12, 2014
Diversity-oriented synthesis-facilitated medicinal chemistry: toward the development of novel antimalarial agentsEamon Comer, Jennifer A Beaudoin, Nobutaka Kato, et al.
The Journal of Organic Chemistry|August 3, 2012
Synthesis and profiling of a diverse collection of azetidine-based scaffolds for the development of CNS-focused lead-like librariesJason T Lowe, Maurice D Lee, Lakshmi B Akella, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Nature Chemical Biology|October 25, 2016
Structural and conformational determinants of macrocycle cell permeabilityBjörn Over, Pär Matsson, Christian Tyrchan, et al.
The Journal of Organic Chemistry|May 23, 2013
Synthesis of stereochemically and skeletally diverse fused ring systems from functionalized C-glycosidesBaudouin Gerard, Maurice D Lee, Sivaraman Dandapani, et al.
Journal of Computer-Aided Molecular Design|April 16, 2013
An informatic pipeline for managing high-throughput screening experiments and analyzing data from stereochemically diverse librariesCarol A Mulrooney, David L Lahr, Michael J Quintin, et al.
Chemistry & Biology|May 28, 2013
Selective HDAC1/HDAC2 inhibitors induce neuroblastoma differentiationStacey M Frumm, Zi Peng Fan, Kenneth N Ross, et al.
Journal of Medicinal Chemistry|July 24, 2023
Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug ConjugatesJeremy R Duvall, Joshua D Thomas, Raghida A Bukhalid, et al.
ACS Infectious Diseases|February 21, 2017
Identification of Highly Specific Diversity-Oriented Synthesis-Derived Inhibitors of Clostridium difficileJeremy R Duvall, Leanne Bedard, Adel M Naylor-Olsen, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Diversity-oriented synthesis yields a new drug lead for treatment of chagas diseaseSivaraman Dandapani, Andrew R Germain, Ivan Jewett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2025
XMT-2056, a HER2-Directed STING Agonist Antibody-Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune CellsRaghida A Bukhalid, Jeremy R Duvall, Kelly Lancaster, et al.
Journal of Medicinal Chemistry|September 12, 2014
Diversity-oriented synthesis-facilitated medicinal chemistry: toward the development of novel antimalarial agentsEamon Comer, Jennifer A Beaudoin, Nobutaka Kato, et al.
The Journal of Organic Chemistry|August 3, 2012
Synthesis and profiling of a diverse collection of azetidine-based scaffolds for the development of CNS-focused lead-like librariesJason T Lowe, Maurice D Lee, Lakshmi B Akella, et al.
Pageof 4